Login / Signup

Emerging systemic drugs in the treatment of plaque psoriasis.

Esther A BaloghArjun M BashyamRima I GhamrawiSteven Richard Feldman
Published in: Expert opinion on emerging drugs (2020)
Many patients with psoriasis have mild disease, and many with mild disease do not seek medical care for their condition. Many patients with mild disease could be adequately treated with topical treatments and phototherapy; however, adherence and feasibility have often been an issue with these treatment types. There seems to be limited room for development of novel biologics, as the existing ones are extraordinarily safe, effective, and convenient with few injections. Patients would prefer a safe, effective oral treatment; however, JAK inhibitors seem unlikely to fill this role completely.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • type diabetes
  • metabolic syndrome
  • combination therapy
  • peritoneal dialysis
  • replacement therapy
  • insulin resistance
  • smoking cessation
  • platelet rich plasma